No abstract

AMAÇ: ‘‘Coronavirus Disease 19’’ salgını pandemi olarak etkisini tüm dünyada sürdürmekte iken; ülkemizde pandemik aşı uygulamaları 14 Ocak 2021 tarihinde başladı. Bu çalışmada; Afyonkarahisar Sağlık Bilimleri Üniversitesi COVID-19 aşı polikliniğinde SARS-CoV-2 aşı uygulaması yapılan kişilerin demografik özellikleri, aşılama öncesi riskli temas öyküleri ve pandemi aşılamaları konusundaki görüşlerinin değerlendirilmesi amaçlanmıştır. GEREÇ VE YÖNTEM: Pandemik aşı uygulamalarının ilk başladığı dönemde; birinci doz pandemik aşı uygulaması yapılan kişilere 17 sorudan oluşan anket yüz yüze görüşme yoluyla uygulandı. Sağlık çalışanları A grubu, diğer katılımcılar B grubu olarak sınıflandırılıp, bu iki grubun aşı olmayı isteme nedenleri, pandemiden etkilenme durumları ve diğer cevapları karşılaştırıldı. BULGULAR: Çalışma periyodu içinde 3159 kişi aşılandı; 1682’si (%53) sağlık çalışanı olup A grubu, geri kalan1477 (% 47) kişi B grubu olarak değerlendirildi. A grubunun anlamlı olarak daha fazla bilimsel yayınlardan, B grubunun ise medyadan bilgi edindiği görüldü. Aşılanma nedenleri sorgulandığında; yakınlarına hastalık bulaştırmaktan korkma, aşı etkinliğine ve koruyuculuğuna inanma, kısıtlamalardan kurtulup normal yaşama dönme gerekçesi ile aşı olanların oranı, A grubunda B grubundan anlamlı olarak yüksek bulundu. SONUÇ: Bu çalışmanın en önemli sonucu, hastalığı ağır geçirme riski olan kişilerin aşı ile ilgili bilgilere sağlık çalışanlarına göre daha yüksek oranda medyadan ulaşması olup toplumun daha doğru kaynaklardan bilgilendirilmesi için tedbir alınması konusunda uyarıcı olmasıdır.

Examining the Coronavirus disease 2019 (COVID-19) vaccination rates and associated factors for acceptance of vaccination in pregnant women during the pandemic. The present study has a cross-sectional survey-based design that evaluated 448 pregnant women, and data were collected between October 1 and December 31, 2021. A composite questionnaire with an instrument was utilized in the survey to examine vaccine rates, including socio demographic data, maternal characteristics, vaccination history, and reasons for not vaccinating. The vaccination rate was 48% (n=216). The main concerns and barriers to non-vaccination were: (i) concerns about pregnancy (82.9%), (ii) possible vaccine side effects (76.3%), and (iii) insufficient trust in the reliability of the vaccine (20.3%). A multiple logistic regression analysis revealed that following factors affect COVID-19 vaccination rate: first trimester of pregnancy (Odds ratio (OR): 3.40 (95% confidence interval (CI):1.84-6.27), p < 0.001), age 35 and over (OR: 2.96 (95% CI:1.40-6.27), p=0.004), active working status (OR: 4.88 (95% CI:2.57-9.23), p < 0.001). Our study indicated that rates of COVID-19 vaccination are still low in pregnant women. Pregnant females constitute a special vulnerable part of the community. Therefore, targeted communication is needed to raise awareness of vaccine safety in healthcare professionals and pregnant women, and strategies to solve vaccine hesitation. In addition, post-vaccination monitoring is required to collect additional data.

Background/Aim: The definitive diagnosis of COVID-19 disease is made by demonstrating the presence of SARS-CoV-2 in nasopharyngeal swab samples. In patients who present with COVID-19-like symptoms but are found to be PCR negative, lung tomography, physical examination, and specific laboratory findings can guide diagnosis and treatment. This study aims to retrospectively evaluate the clinical, laboratory, and radiological findings of patients who presented with Covid-19-like symptoms. but were found to be PCR negative. Methods: This study was planned as a retrospective cohort study. Patients hospitalized in the pandemic service of Afyonkarahisar Health Sciences University between 19 March and 30 September 2020 - who were PCR negative and defined as possible cases through diagnosis, treatment, and follow-up guidelines of the Republic of Turkey Ministry of Health, were included. Of these patients, those without radiological pulmonary involvement were defined as group A, and those with radiological pulmonary involvement were defined as group B. Clinical and laboratory findings of both groups were evaluated and compared. Results: In the lung tomographic examination of 238 patients in the study, 16.4% in group A without radiological lung findings and 83.6% in group B with signs of inflammation were identified. While common complaints were high fever and diarrhea in group A, cough and shortness of breath were significantly higher in group B. The most common comorbidities in both groups were hypertension and diabetes, respectively, while hypertension was found to be significantly higher in group B. There was no mortality in any patient without lung involvement, but there was no significant difference between groups in terms of mortality. Conclusion: These techniques can be used in PCR-negative patients presenting with COVID-19, for an estimation of patients with a severe prognosis with pulmonary tomography findings, symptoms, laboratory results, and accompanying disease at the time of admission. Determining parameters that identify at-risk patients during the early period may contribute to improving patient management and the appropriate use of limited resources.

No abstract